MBX Biosciences | 10-Q: Quarterly report

SECNov 7 08:33 ET · Announcements

Express News | Mbx Biosciences: Strong Cash Position, With $277.1 Mln Expected to Support Operations Into Mid-2027

ReutersNov 7 08:09 ET

MBX Biosciences Reports Q3 EPS ($2.78), Consensus ($2.72)

TipRanksNov 7 08:08 ET

MBX Biosciences 3Q Research and Development Expenses $16.7M >MBX

Dow JonesNov 7 08:07 ET

Earnings Flash (MBX) MBX BIOSCIENCES Posts Q3 Loss $-2.78 Per Share

MT NewswiresNov 7 08:04 ET

Express News | Mbx Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Update

ReutersNov 7 08:00 ET